Kinase inhibitors for the treatment of inflammatory and autoimmune disorders

被引：39

作者：

Bhagwat, Shripad S. ^{[1
]}

机构：

[1] Ambit Biosci, San Diego, CA 92121 USA

来源：

PURINERGIC SIGNALLING | 2009年 / 5卷 / 01期

关键词：

Kinase inhibitors; Anti-inflammatory agents; Autoimmune modulators; IKK2; inhibitors; Syk inhibitors; Lck inhibitors; JAK3; KAPPA-B KINASE; IKK-BETA INHIBITORS; POTENT; DISCOVERY; SYK; JAK3; LCK; SAR; DERIVATIVES; BMS-345541;

D O I：

10.1007/s11302-008-9117-z

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Drugs targeting inhibition of kinases for the treatment of inflammation and autoimmune disorders have become a major focus in the pharmaceutical and biotech industry. Multiple kinases from different pathways have been the targets of interest in this endeavor. This review describes some of the recent developments in the search for inhibitors of IKK2, Syk, Lck, and JAK3 kinases. It is anticipated that some of these compounds or newer inhibitors of these kinases will be approved for the treatment of rheumatoid arthritis, psoriasis, organ transplantation, and other autoimmune diseases.

引用

收藏

页码：107 / 115

页数：9

相关论文

共 50 条

[31] Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors [J].

Guan, Ronggui ;

Xu, Xiaoyu ;

Chen, Meihui ;

Hu, Haiyan ;

Ge, Hu ;

Wen, Shijun ;

Zhou, Shiyou ;

Pi, Rongbiao .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 :613-622

[32] Inhibitors of Cyclin-Dependent Kinase 1/2 for Anticancer Treatment [J].

Mou, Jiajia ;

Chen, Danghui ;

Deng, Yanru .

MEDICINAL CHEMISTRY, 2020, 16 (03) :307-325

[33] Investigational Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis [J].

Norman, Peter .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (08) :891-899

[34] Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases [J].

Clark, James D. ;

Flanagan, Mark E. ;

Telliez, Jean-Baptiste .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (12) :5023-5038

[35] The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases [J].

Bai, Yi-Ru ;

Yang, Wei-Guang ;

Hou, Xue-Hui ;

Shen, Dan-Dan ;

Zhang, Sheng-Nan ;

Li, Yan ;

Qiao, Yan-Yan ;

Wang, Sai-Qi ;

Yuan, Shuo ;

Liu, Hong-Min .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258

[36] Interleukin-1 receptor associated kinase inhibitors: Potential therapeutic agents for inflammatory- and immune-related disorders [J].

Bahia, Malkeet Singh ;

Kaur, Maninder ;

Silakari, Pragati ;

Silakari, Om .

CELLULAR SIGNALLING, 2015, 27 (06) :1039-1055

[37] Janus kinase inhibitors for the treatment of psoriatic arthritis [J].

Raychaudhuri, Sanchita ;

Shah, Ruchi Jayeshbhai ;

Raychaudhuri, Smriti K. ;

Raychaudhuri, Siba P. .

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (02) :186-191

[38] Emerging kinase inhibitors of the treatment of gastric cancer [J].

Vincenzi, Bruno ;

Imperatori, Marco ;

Silletta, Marianna ;

Marrucci, Eleonora ;

Santini, Daniele ;

Tonini, Giuseppe .

EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (03) :479-493

[39] Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis [J].

Hulverson, Matthew A. ;

Choi, Ryan ;

Vidadala, Rama S. R. ;

Whitman, Grant R. ;

Vidadala, Venkata Narayana ;

Ojo, Kayode K. ;

Barrett, Lynn K. ;

Lynch, James J. ;

Marsh, Kennan ;

Kempf, Dale J. ;

Maly, Dustin J. ;

Van Voorhis, Wesley C. .

ACS INFECTIOUS DISEASES, 2021, 7 (05) :1200-1207

[40] Tyrosine kinases as new molecular targets in treatment of inflammatory disorders and leukemia [J].

Uckun, FM ;

Mao, C .

CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (10) :1083-1091

← 1 2 3 4 5 →